In a historic move, Australia has given the go-ahead to the use of 3,4-Methylenedioxymethamphetamine-assisted therapy as a prescription option for sufferers dealing with severe post-traumatic stress disorder . This pivotal decision, following extensive research , click here permits trained clinicians to administer the drug in a controlled space to